From April 2016, low voltage directive 2006/95/EC will be repealed by the new 2014/35/EU LVD.

From April 2016, low voltage directive 2006/95/EC will be repealed by the new 2014/35/EU LVD.
Will cetylpyridinium chloride be the next preservative allowed for use under Annex V of the 1223/2009/EC cosmetics regulation? Find out more with Obelis.
The Scientific Committee on Consumers Safety's opinion finally addresses concerns surrounding the safety of α-Arbutin, β-Arbutin and Deoxyarbutin in cosmetics.
The EU Commission proposes new regulatory guidelines for product labelling on cosmetic fragrances containing allergens sold on the EU market.
Explaining the difference between EU and FDA compliance under the new EU medical device regulation. Learn more about registration, notified bodies and more.
It has been announced that the Transatlantic Trade and Investment Partnership will not have any influence on cosmetics ingredients previously banned in the EU.
In many cases it is possible for some products to have found their way onto the European Market without having undergone the proper Compliance screening processes or having been awarded an official CE Marking. In these types of cases, manufacturers may well feel that there is no real pull factor to encourage them to seek CE certification and that the onus to request information on such issues falls outside the realm of their responsibility.
The EC have requested the Scientific Committee on Consumers Safety issue an opinion on the safety of skin-whitening ingredient Arbutin in cosmetic products.
The EU medical device regulation has created a new category known as 'Aesthetic Devices'. These are defined as devices “without and intended medical purpose”.
The SCCS' verdict on the use of dichloromethane in cosmetics products under regulation 1223/2009 is open until March 15th 2015.